Company news
Entropy Neurodynamics Limited news in 2023
Entropy Neurodynamics Limited's news releases, calls and decks from 2023, newest first.
Further management changes and cost-reductions
November 27, 2023
Suspension from Quotation
October 2, 2023
FY2023 Appendix 4E
August 28, 2023
EX1 early stage success with in house Elastin (ELN) program
April 27, 2023
Results of Non-Renounceable Rights Issue
April 25, 2023
Exopharm Limited announces Non-Renounceable Pro Rata Rights
March 22, 2023
Disclosure Document - Rights Issue Prospectus
March 22, 2023
EX1 to Receive $1m from the Issue of Convertible Notes
March 9, 2023
EX1 to Receive $0.431m in Prepayment of R&D Tax Incentive
March 8, 2023
Appendix 4D and Half Year Report for period 31 December 2022
February 26, 2023
Added Funding for 2023
February 12, 2023